Skip to content

The Role of Local Long Acting Corticosteroid Injection in Hypospadias Surgery.

Prospective Comparative Trial to Assess the Role of Local Long Acting Steroid Injection After Hypospadias Surgery in Decreasing Complications and Preserving Better Cosmesis

Status
UNKNOWN
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04196400
Enrollment
40
Registered
2019-12-12
Start date
2019-12-01
Completion date
2021-03-01
Last updated
2019-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypospadias

Keywords

hypospadias, edema, failure, fistula, steroids

Brief summary

Post-operative tissue oedema is one of the main causes of failure of hypospadias repair. Severe oedema may disrupt the suture line, invite infection and result in repair failure. Thus, we suggested that local injection of corticosteroids in just below coronal sulcus into dartos and buck's fascia may limit this oedema thus improving the outcome of hypospadias repair.

Detailed description

This is a prospective comparative trial : comparing the use of local steroids injection to reduce tissue edema after hypospadias and to preserve the final cosmesis after tissue repair. The patients will be divided into 2 groups(each group 20 patients): one group will be injected steroids just after hypospadias surgery while the other will not. The short and long term outcomes between both groups will be compared.

Interventions

DRUGsteroid betamethasone

The steroid is injected using insulin needle in the subcutaneous tissue after finishing the repair

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Intervention model description

comparative prospective clinical trial

Eligibility

Sex/Gender
MALE
Age
6 Months to No maximum
Healthy volunteers
No

Inclusion criteria

* Hypospadias Patient * Recurrent Cases * 6 months or more * Distal, and mid penile hypospadias

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frame
Failure rate2 weeks

Secondary

MeasureTime frameDescription
incidence of Tissue edema3 days, 5 days, 10 days, 2 weeks
Infection Rate3 days, 5 days, 10 days, 2 weeks
Fistula rate2 weeks
Final cosmesis3 days, 5 days, 10 days, 2 weeksThe shape of the glans penis and surrounding tissue

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026